Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics have?
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics has 112 citations in the OpenAlex counts ScholarIQ stores.
When was Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics published?
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics has 2019 year in the ScholarIQ index.
What is the open-access status of Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics?
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics has closed oa status in the ScholarIQ index.
What is the DOI of Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics?
The DOI for Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics is on the source record.
What is the PMID of Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics?
The PMID for Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics is on the source record.
What is the OpenAlex record for Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics?
The OpenAlex for Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics is on the source record.